Fulfilling unmet needs

CognivAiD introduces a new approach to the treatment of dementia with its innovative therapeutic strategy.

CognivAiD contains Croci Stigma, Ginkgo Folium and Ginseng Radix et Rhizoma

A novel approach

Neurological conditions involve multiple complex and interconnected biological processes. CognivAiD employs a multi-modal approach that simultaneously targets key disease-causing mechanisms of vascular dementia.

Evidence-Based Development


  • EEstablished pharmacological properties and mechanisms of action
  • EScientifically researched
  • EPost-marketing surveillance
Microscope used in scientific research

represents a new generation of evidence-based natural products and a long-awaited addition to the treatment armamentarium of dementia.